ABVX (ABVX) Stock Price & Analysis
ABVX (ABVX) rose 0.00% to USD 125.7 as of July 25, 2026 at 03:48 UTC, according to Nexqual real-time market data.
ABVX last closed at USD 125.7; the session ranged USD 125.68–133.23 on volume of 947,521 shares. Market capitalization is —, with a 52-week range of USD 65.67–148.83 (NGM). Source: Nexqual, July 25, 2026 at 03:48 UTC.
Key Statistics (as of July 25, 2026 at 03:48 UTC)
| Price | USD 125.7 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 125.7 |
| Open | USD 125.7 |
| Day Range | USD 125.68 – 133.23 |
| 52-Week Range | USD 65.67 – 148.83 |
| Volume | 947,521 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ABVX)
Nexqual's technical model rates ABVX "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:48 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.82 (neutral) |
| vs SMA50 | Above (USD 117.83) |
| MACD | 4.59 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CELC | Celcuity Inc. | USD 82.62 | ▼ 8.34% |
| PRAX | Praxis Precision Medicines, Inc | USD 325.3 | ▲ 4.23% |
| ALMS | Alumis Inc. | USD 28 | ▼ 2.81% |
| GPCR | Structure Therapeutics Inc. | USD 49.12 | ▼ 2.56% |
| TNGX | Tango Therapeutics, Inc. | USD 26.63 | ▼ 5.23% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:48 UTC. This page is informational and not investment advice.